Posted by ASA National | February 9, 2012
The legalization of medicinal cannabis in a growing number of states and countries has opened up new areas of study and research, which is very exciting to the industry in general, and thrilling toGreenway doctors, who pride themselves in keeping up with the latest developments and passing essential information on to their patients.
San Francisco, CA (PRWEB) February 09, 2012
The professional staff at Greenway Medical Marijuana Physician Evaluations in San Francisco is witnessing a significant increase in the amount of research and studies around the medical benefits of cannabis as medicinal use of the drug spreads through many parts of the world. From its pain killing anti-inflammatory properties to its strong antibiotic properties, studies continue to prove marijuana’s effectiveness for treating a wide range of serious medical conditions. Greenway applauds the efforts of the scientists who are proving cannabis is good medicine for many patients with serious illnesses.
“There are several areas of cannabis research—especially concerning cancer, pain management, and antibiotic applications—that are moving swiftly forward,” said Penny DeVries of Medical Marijuana Physician Evaluations in San Francisco. “These studies, which are being conducted primarily in Europe and Israel, keep us optimistic about our work treating serious illnesses with cannabis-based medications.”
DeVries points to a recent Israeli study of 264 cancer patients that found two-thirds of participants reported improvement in quality of life from using medical marijuana to treat cancer. The patients used marijuana to alleviate cancer and chemotherapy symptoms such as nausea and pain. The study, presented by the Israeli Oncologists Union, concluded, “The treatment should be offered to the patients in earlier stages of cancer.”
Findings from another recent study indicate a claim of medical marijuana doctors have maintained for years, that patients can not only safely use cannabis while taking addictive and dangerous opioid painkillers, like morphine and oxycodone (Oxycontin), they are often able to experience the same level of pain relief by combining cannabis-based products with reduced amounts of opiate-based drugs.
Targeted studies from GW Pharmaceuticals, the UK company that has led the world in cannabis research for over a decade, indicate cannabis-based medications may provide relief from pain associated with diseases that cause inflammation, especially rheumatoid arthritis, colitis and neuroinflammation.
In addition to use as a pain reliever, cannabis-based medications are proving effective for use on other serious medical conditions. The most promising research results on the antibacterial properties of cannabis used in the treatment of a virulent form of staph infection comes from the England and Italy. MRSA, short for methicillin-resistant staphylococcus aureus, is a bacterium that can cause difficult-to-treat infections because of its growing resistance to antibiotic therapy.
Researchers have found that certain cannabinoids have the same effectiveness as vancomycin, a powerful antibiotic used as a last resort to fight MRSA when other drugs fail. The research also indicates that the two most effective cannabinoids at treating MRSA are nonpsychoactive, meaning that they do not get people “high.”
DeVries points out that non-psychoactive cannabis-based sprays and balms are available at many dispensaries in California. In addition to its antibacterial properties, DeVries says that Greenway patients report many of these cannabis-based topical preparations are effective for treating localized pain and inflammation.
“Patients report the cannabis-based products are fast acting and usually have little to no smell,” said DeVries. “Cannabis has few side effects and does not interact negatively with most pharmaceuticals, so it makes an ideal complement to other pain management drugs.
Greenway provides a compassionate, non-judgmental and a detailed evaluation of each patient’s medical problem, then formulates an individualized treatment plan which incorporates the different strains of cannabis. Greenway doctors are available for follow-up consultations, and Greenway’s consulting attorney is available for legal guidance.
Greenway has become the premier San Francisco Bay Area medical marijuana clinic by providing a compassionate, non-judgmental and detailed evaluation of each patient’s medical problem, then formulating an individualized treatment plan.
Greenway’s doctors and front office staff are cannabis-knowledgeable, and the San Francisco medicalmarijuana clinic keeps an attorney on retainer to answer legal questions for patients that the staff cannot answer. The clinic guarantees 100% patient privacy, per HIPPA guidelines, and compliance with all California laws.
The Greenway San Francisco medical cannabis doctors are located in downtown San Francisco at 965 Mission Street, #212, between 5th and 6th Streets—one block from the Powell Street BART Station. Hours of operation are Monday through Friday from 11 am to 5 pm, and Saturdays from 10 am to 2 pm.
For more information, contact Greenway at (415) 777-0157. In order to make an appointment at Greenway, please email appointment(at)greenway420(dot)com.
About Greenway Medical Marijuana Physicians Evaluations
Greenway Medical Marijuana Physicians Evaluations is a downtown San Francisco medical marijuana clinic. Greenway provides efficient, low-cost medical evaluations to the qualifying public for medicinal marijuana access. Greenway’s San Francisco medical marijuana doctors formulate individualized treatment plans during compassionate, non-judgmental and detailed evaluations of each patient’s medical problems.
Greenway Medical Marijuana Physicians Evaluations
Latest posts by ASA National (see all)
- Wasted: Cops Burn Millions in Failed Marijuana Cases - November 17, 2013
- Dire Warnings about Medical Marijuana in California Turned out to be Wrong - October 31, 2013
- Few Problems With Cannabis for California - October 26, 2013